Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100044012Phase 4Recruiting
Phase 4 trial of desflurane, sevoflurane, remifentanil and alfentanil in peripheral nerve sheath neoplasm and peripheral functional tumor (2 arms), sponsored by Fushun Mining Bureau General Hospital. Primary endpoints: Blood pressure, Heart rate and 2 more. Started Mar 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100044012.